Skip to main content
Download PDF

Correction: Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses

BMC Cancer volume 22, Article number: 822 (2022) Cite this article

The Original Article was published on 22 June 2022

Correction: BMC Cancer 22, 687 (2022)

https://doi.org/10.1186/s12885-022-09763-2

Following publication of the original article [1], the authors identified a production error. Figure 8 was not correctly processed by the publisher. The correct version of figure 8 is supplied in this correction article.

Fig. 8
figure 1

RMSD and RMSF of the SARS-CoV-2 Mpro complexes and DDP4 complexes. A The RMSD of Mpro. B The RMSD of DDP4. C The RMSD of inhibitor 11a and emetine. D The RMSD of omarigliptin and emetine. E The RMSF of Mpro. F The RMSF of DDP4

Full size image

Reference

  1. Zhang K, Wang K, Zhang C, et al. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer. 2022;22:687. https://doi.org/10.1186/s12885-022-09763-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory and Critical Care Medicine, First Afliated Hospital of Xi’an Jiaotong University, No. 277 Yanta West Road, Xi’an, 710061, Shaanxi Province, China

    Kun Zhang, Ke Wang, Chaoguo Zhang, Xiuli Teng, Dan Li & Mingwei Chen

Authors
  1. Kun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ke Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chaoguo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiuli Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mingwei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mingwei Chen.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, K., Wang, K., Zhang, C. et al. Correction: Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer 22, 822 (2022). https://doi.org/10.1186/s12885-022-09836-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-09836-2

BMC Cancer

ISSN: 1471-2407

Contact us